InspireMD, Inc. is medical device company, which engages in the development and commercialization of its proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The firm is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). The company markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. The company is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.
Mr. Marvin Slosman is the President of InspireMD Inc, joining the firm since 2020.
What is the price performance of NSPR stock?
The current price of NSPR is $1.78, it has decreased 0.55% in the last trading day.
What are the primary business themes or industries for InspireMD Inc?
InspireMD Inc belongs to Health Care industry and the sector is Health Care
What is InspireMD Inc market cap?
InspireMD Inc's current market cap is $75.4M
Is InspireMD Inc a buy, sell, or hold?
According to wall street analysts, 4 analysts have made analyst ratings for InspireMD Inc, including 2 strong buy, 5 buy, 1 hold, 0 sell, and 2 strong sell